| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002692173 |
| P356 | DOI | 10.1038/NRENDO.2012.28 |
| P698 | PubMed publication ID | 22371161 |
| P2093 | author name string | John C Pickup | |
| P2860 | cites work | Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes | Q83152730 |
| Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus | Q83485650 | ||
| Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps | Q84347920 | ||
| Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus | Q24240609 | ||
| When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009. | Q30976691 | ||
| Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life | Q33183994 | ||
| In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. | Q33321671 | ||
| Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. | Q33365408 | ||
| Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy | Q33403231 | ||
| Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation | Q33540052 | ||
| Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data | Q33954163 | ||
| Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials | Q34010466 | ||
| Insulin patch pumps: their development and future in closed-loop systems | Q34076632 | ||
| Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial | Q34133095 | ||
| Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes | Q34718324 | ||
| Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetes | Q34998747 | ||
| Insulin pump therapy: a meta-analysis | Q35094023 | ||
| Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk | Q35179907 | ||
| Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine | Q35938675 | ||
| Continuous glucose monitoring: roadmap for 21st century diabetes therapy | Q36108412 | ||
| Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials | Q36902231 | ||
| Will long acting insulin analogs influence the use of insulin pump therapy in type 1 diabetes? | Q37065474 | ||
| Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes | Q37069936 | ||
| Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion | Q37222743 | ||
| Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. | Q37235857 | ||
| Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections | Q37352466 | ||
| Assessing quality of life for new diabetes treatments and technologies: a simple patient-centered score | Q37403871 | ||
| Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements? | Q37689902 | ||
| Insulin pumps and their use in pregnancy | Q37761920 | ||
| Using insulin pump therapy in poorly controlled type 2 diabetes | Q37767088 | ||
| Contemporary management of patients with type 1 diabetes | Q37781156 | ||
| Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment? | Q39207609 | ||
| A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements | Q41181511 | ||
| Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial | Q42607329 | ||
| Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial | Q42625907 | ||
| Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment | Q42936771 | ||
| Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen | Q42976169 | ||
| A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance | Q43115619 | ||
| The use of continuous insulin delivery systems in severely insulin-resistant patients | Q43651913 | ||
| Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 y | Q44122835 | ||
| A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control | Q44195346 | ||
| Sustained benefits of continuous subcutaneous insulin infusion | Q44373134 | ||
| Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection | Q44518159 | ||
| Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study | Q44563965 | ||
| Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial | Q44599148 | ||
| Continuous subcutaneous insulin infusion in diabetes mellitus type 1 and 2: lower HbA1c-values and a high level of patient satisfaction | Q44637838 | ||
| Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada | Q44947081 | ||
| A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine | Q44953969 | ||
| Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. | Q45124449 | ||
| Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. | Q45285681 | ||
| Psychological aspects in continuous subcutaneous insulin infusion: a retrospective study | Q46078551 | ||
| Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study | Q46261671 | ||
| Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII). | Q46307248 | ||
| Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus | Q46385957 | ||
| Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system | Q46460184 | ||
| International survey of insulin pump users: Impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life | Q46480626 | ||
| Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. | Q46606057 | ||
| Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus | Q46803810 | ||
| Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability | Q46876719 | ||
| Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial | Q46909176 | ||
| Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions | Q46974796 | ||
| Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study | Q49106774 | ||
| Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control? | Q50645863 | ||
| Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. | Q51042927 | ||
| Are insulin pumps underutilized in type 1 diabetes? Yes. | Q51191418 | ||
| Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. | Q51369808 | ||
| A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. | Q51420443 | ||
| Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. | Q51565054 | ||
| Efficacy of continuous subcutaneous insulin infusion in type 2 diabetes mellitus: a survey on a cohort of 102 patients with prolonged follow-up. | Q51740737 | ||
| Is insulin pump therapy better than injection for adolescents with diabetes? | Q53075480 | ||
| Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. | Q53473069 | ||
| Pharmacokinetics of continuous subcutaneous insulin infusion | Q60895399 | ||
| Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia | Q66885252 | ||
| The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial | Q71580033 | ||
| Convenient pocket insulin syringe | Q72450985 | ||
| Continuous subcutaneous insulin infusion: Comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose | Q72472182 | ||
| Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes | Q73143654 | ||
| Insulin analogues | Q81264332 | ||
| Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia | Q81336904 | ||
| Retrospective Analysis and Patient Satisfaction Assessment of Insulin Pump Therapy in Patients with Type 2 Diabetes | Q82463588 | ||
| NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidance | Q83151643 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 425-433 | |
| P577 | publication date | 2012-02-28 | |
| P1433 | published in | Nature Reviews Endocrinology | Q2079257 |
| P1476 | title | Management of diabetes mellitus: is the pump mightier than the pen? | |
| P478 | volume | 8 |
| Q90405095 | A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5) |
| Q30653146 | Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies. |
| Q52679965 | Automatic Adaptation of Basal Insulin Using Sensor-Augmented Pump Therapy. |
| Q38262799 | Banting Memorial Lecture 2014* Technology and diabetes care: appropriate and personalized |
| Q26745886 | Coming of age: the artificial pancreas for type 1 diabetes |
| Q88312484 | Continuous Glucose Monitoring Adoption in the United Kingdom - An Economic and Policy Perspective |
| Q53489843 | Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus. |
| Q38652925 | Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons |
| Q28601478 | Diabetes Device Interoperability for Improved Diabetes Management |
| Q37022673 | Glucose variability assessed by low blood glucose index is predictive of hypoglycemic events in patients with type 1 diabetes switched to pump therapy. |
| Q34396440 | Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54. |
| Q38205861 | Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems |
| Q99565694 | Insulin-delivery methods for children and adolescents with type 1 diabetes |
| Q62774275 | Insulintherapie bei Diabetes mellitus |
| Q62774815 | Insulintherapie bei Diabetes mellitus |
| Q64066044 | Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control |
| Q36574654 | Managing diabetes with nanomedicine: challenges and opportunities |
| Q27025548 | Patient safety and minimizing risk with insulin administration - role of insulin degludec |
| Q47753615 | Rational Design of Glucose-Responsive Insulin Using Pharmacokinetic Modeling |
| Q61684785 | Regulation of medical devices used in diabetology in Europe: Time for reform? |
| Q50904654 | Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment. |
| Q37024022 | Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels |
| Q30409804 | The evidence base for diabetes technology: appropriate and inappropriate meta-analysis |
| Q50123365 | The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis. |
Search more.